Abstract
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, with a frequency in the general population of 2% and continues to increase [1]. AF affects the quality of life of patients and reduces life expectancy. AF is believed to be an independent risk factor for cardiovascular disease. According to the latest recommendations for the diagnosis and treatment of AF, there are 5 types of arrhythmias: first detected, paroxysmal, persistent, prolonged persistent and persistent [1]. The majority of patients with AF progresses to a persistent or permanent form, leading to a worsening of the clinical picture of patients and their prognosis.